References
Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391–404
Yaguchi H, Yabe I, Takahashi H et al (2014) Identification of anti-Sez6l2 antibody in a patient with cerebellar ataxia and retinopathy. J Neurol 261(1):224–226
Landa J, Guasp M, Petit-Pedrol M et al (2020) Seizure-related 6 homolog like 2 autoimmunity: neurologic syndrome and antibody effects. Neurol Neuroimmunol Neuroinflamm 8(1):e916
Mehdiyeva A, Hietaharju A, Sipilä J (2022) SEZ6L2 Antibody–associated cerebellar ataxia responsive to sequential immunotherapy. Neurol Neuroimmunol Neuroinflamm 9(2):e1131
Shen K, Xu Y, Guan H et al (2018) Paraneoplastic limbic encephalitis associated with lung cancer. Sci Rep 8(1):6792
Coevorden-Hameete MH, Bruijn MA, Graaff E et al (2019) The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. Brain 142(6):1631–1643
Ishikawa N, Daigo Y, Takano A, Taniwaki M, Kato T, Tanaka S, Yasui W, Takeshima Y, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y (2006) Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer. Cancer Sci 97(8):737–745
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval and Informed consent statement
Ethical approval and informed consent were obtained.
Conflict of interest
The authors report no conflict of interest related to this article.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Reis Carneiro, D., Maresch, Â., Cunha, R. et al. Sez6l2-associated encephalitis in a patient with small-cell lung cancer. Neurol Sci 43, 6131–6133 (2022). https://doi.org/10.1007/s10072-022-06244-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06244-z